기업명 | 주식 심볼 | 시장 | 주식 타입 |
---|---|---|---|
Kyverna Therapeutics Inc | KYTX | 나스닥 | 보통주 |
개장가 | 저가 | 고가 | 종가 | 전일 종가 |
---|---|---|---|---|
13.33 | 12.16 | 13.33 | 13.33 |
최근 뉴스
일자 | 시간 | 출처 | 제목 |
---|---|---|---|
15/05/2024 | 05:29 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
15/05/2024 | 05:25 | EDGAR2 | Form 8-K - Current report |
15/05/2024 | 05:05 | PRNUS | Kyverna Therapeutics Provides Business Update and Reports.. |
12/04/2024 | 06:01 | PRNUS | Kyverna Therapeutics to attend the 2024 American Academy of.. |
30/03/2024 | 03:59 | PRNUS | First-in-Disease Use of Kyverna Therapeutics' KYV-101 in.. |
27/03/2024 | 05:05 | PRNUS | Kyverna Therapeutics Provides Business Update and Reports.. |
08/03/2024 | 09:26 | PRNUS | Kyverna Therapeutics and Stanford University Agree to.. |
13/02/2024 | 06:39 | PRNUS | Kyverna Therapeutics Announces Closing of Initial Public.. |